Search results for "PDA"

showing 10 items of 78 documents

On optimizing firewall performance in dynamic networks by invoking a novel swapping window-based paradigm

2018

Designing and implementing efficient firewall strategies in the age of the Internet of Things (IoT) is far from trivial. This is because, as time proceeds, an increasing number of devices will be connected, accessed and controlled on the Internet. Additionally, an everincreasingly amount of sensitive information will be stored on various networks. A good and efficient firewall strategy will attempt to secure this information, and to also manage the large amount of inevitable network traffic that these devices create. The goal of this paper is to propose a framework for designing optimized firewalls for the IoT. This paper deals with two fundamental challenges/problems encountered in such firewalls…

Non-stationary environmentsFirewall optimizationsMatching timesWeak estimatorsBatch updatesLearning automata
researchProduct

Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of…

2021

Abstract Approaches to improve pancreatic cancer therapy are essential as this disease has a very bleak outcome. Approximately 80% of pancreatic cancers are pancreatic ductal adenocarcinomas (PDAC). A key regulatory gene frequently mutated (∼75%) in PDAC is the TP53 tumor suppressor gene which controls the transcription of multiple genes involved in cell cycle progression, apoptosis, cancer progression and other growth regulatory processes. The mouse double minute 2 homolog (MDM2) gene product is a nuclear-localized E3 ubiquitin ligase and negatively regulates the TP53 protein which results in its proteasomal degradation. Various MDM2 inhibitors have been isolated and examined in clinical t…

Nutlin-3aCancer ResearchBerberineendocrine system diseasesTumor suppressor geneNAX compoundsApoptosisPiperazinesTargeted therapyGene productCell Line TumorPancreatic cancerGeneticsmedicineHumansTP53neoplasmsMolecular BiologyRegulator geneNAX compundsbiologyChemistryImidazolesPDACCancerProto-Oncogene Proteins c-mdm2PDCAmedicine.diseaseUbiquitin ligasePancreatic NeoplasmsCell culturebiology.proteinCancer researchNAX compoundMolecular MedicineMdm2Tumor Suppressor Protein p53Signal TransductionAdvances in Biological Regulation
researchProduct

An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting TKI-based therapy.

2019

Introduction: The angiogenesis mechanism is considered a crucial point in neoplastic development. A growing number of multi-targeted tyrosine kinase inhibitors (TKI) has been developed and approved for cancer treatment during the last few years. Cardiac side effects still remain an issue to manage nowadays. These drugs mechanisms and toxicities have already been discussed, hence the authors will report updates on these already available drugs. Area covered: This manuscript provides an updated review on the new mechanisms involved in angiogenesis and cardiotoxicity that are TKI-related. Here is reported an overview of the already available and the most recent TKIs under investigation in the …

OncologyTumor angiogenesismedicine.medical_specialtyAngiogenesisupdateVEGFR-TKIAngiogenesis InhibitorsAntineoplastic Agents030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineNeoplasmsmedicineAnimalsHumansPharmacology (medical)Cardio oncologyCooperative BehaviorCrucial pointProtein Kinase InhibitorsNeovascularization Pathologicbusiness.industrycardiovasculartoxicityGeneral MedicineCardiotoxicityrespiratory tract diseasesReceptors Vascular Endothelial Growth Factor030220 oncology & carcinogenesisoncologybusinessTyrosine kinasemanagementExpert opinion on drug safety
researchProduct

The potential of serum neurofilament as biomarker for multiple sclerosis

2021

Abstract Multiple sclerosis is a highly heterogeneous disease, and the detection of neuroaxonal damage as well as its quantification is a critical step for patients. Blood-based serum neurofilament light chain (sNfL) is currently under close investigation as an easily accessible biomarker of prognosis and treatment response in patients with multiple sclerosis. There is abundant evidence that sNfL levels reflect ongoing inflammatory-driven neuroaxonal damage (e.g. relapses or MRI disease activity) and that sNfL levels predict disease activity over the next few years. In contrast, the association of sNfL with long-term clinical outcomes or its ability to reflect slow, diffuse neurodegenerativ…

Oncologymedicine.medical_specialtyTreatment responseMultiple SclerosisNeurofilamentFilaments citoplasmàticsDiseaseneurofilamentUpdatesNeurofilament ProteinsInternal medicinemedicineHumans:aminoácidos péptidos y proteínas::proteínas::aminoácidos péptidos y proteínas::proteínas::proteínas del tejido nervioso::proteínas de neurofilamentos [COMPUESTOS QUÍMICOS Y DROGAS]Longitudinal StudiesSubclinical disease:Diagnosis::Prognosis [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Esclerosi múltiple - Imatgeria per ressonància magnètica:diagnóstico::pronóstico [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]:Other subheadings::Other subheadings::/diagnostic imaging [Other subheadings]AcademicSubjects/SCI01870business.industrytherapy responseMultiple sclerosis:Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases CNS::Multiple Sclerosis [DISEASES]biomarkers:Otros calificadores::Otros calificadores::/diagnóstico por imagen [Otros calificadores]:Amino Acids Peptides and Proteins::Proteins::Amino Acids Peptides and Proteins::Proteins::Nerve Tissue Proteins::Neurofilament Proteins [CHEMICALS AND DRUGS]Prognosismedicine.diseaseEsclerosi múltiple - PrognosiMagnetic Resonance ImagingClinical trialEarly results:enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES]Biomarker (medicine)AcademicSubjects/MED00310Neurology (clinical)businessBrain
researchProduct

En studie av de faktorer som bidrar til effekter ved PDAbruk i norsk hjemmesykepleie

2006

Masteroppgave i informasjonssystemer 2006 - Høgskolen i Agder, Kristiansand Helsesektoren i Norge er en belastet sektor som skal betjene et økende antall hjemmeboende klienter og bistå dem med helsetjenester og hjelp til daglige gjøremål. Etaten sliter med lav bemanning og begrensede midler. Dette har bidratt til at man har fått fremvekst av moderniseringstiltak i sektoren. Moderniseringen kan ta flere former og denne oppgaven ser i hovedsak på bruk av PDAer i norsk hjemmesykepleie. PDAer er små håndholdte PC-er som kan gi mobil tilgang til informasjon som tidligere var papirbasert og utilgjengelig for pleiepersonell ute på mobile oppdrag. Det er en rekke potensielle effekter ved slike PDA-…

PDAPDA suksessmodellPotensielle og Realiserte effekterNorsk hjemmesykepleiePDA programvareKartleggingIS501ModerniseringTelemedisinVDP::Samfunnsvitenskap: 200::Statsvitenskap og organisasjonsteori: 240::Offentlig og privat administrasjon: 242GevinstrealiseringSuksessfaktorerVDP::Matematikk og naturvitenskap: 400::Informasjons- og kommunikasjonsvitenskap: 420::Systemutvikling og -arbeid: 426
researchProduct

Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal a…

2017

Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells (UCOGC) is currently considered a morphologically and clinically distinct variant of pancreatic ductal adenocarcinoma (PDAC). In this study, we report clinical and pathological features of a series of 22 UCOGCs, including the whole exome sequencing of eight UCOGCs. We observed that 60% of the UCOGCs contained a well-defined epithelial component and that patients with pure UCOGC had a significantly better prognosis than did those with an UCOGC with an associated epithelial neoplasm. The genetic alterations in UCOGC are strikingly similar to those known to drive conventional PDAC, including activating mutations in the…

PDAC variants; Undifferentiated carcinoma with osteoclast-like giant cells; whole exome sequencingAged 80 and overMaleendocrine system diseasesCarcinomaUndifferentiated carcinoma with osteoclast-like giant cellsundifferentiated carcinoma with osteoclast-like giant cellOsteoclastsMiddle AgedImmunohistochemistrydigestive system diseasesArticleNeoplasm Proteinswhole exome sequencingPDAC variants; undifferentiated carcinoma with osteoclast-like giant cells; whole exome sequencing; Aged; Aged 80 and over; Carcinoma Pancreatic Ductal; Exome; Female; Humans; Immunohistochemistry; Male; Middle Aged; Mutation; Neoplasm Proteins; Osteoclasts; Pancreatic NeoplasmsPancreatic NeoplasmsPDAC variantsPancreatic DuctalMutation80 and overHumansExomeFemaleAgedCarcinoma Pancreatic Ductal
researchProduct

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

2016

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and implemented in over 70 countries globally-is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK [MACVIA (Contre les Maladies Chroniques pour un Vieillissement Actif)-ARIA Sentinel NetworK] uses mobile technology to develop care p…

PediatricsAIRWAYS ICPs; ARIA; EIP on AHA; ICT; Mobile technology; Rhinitis; Immunology and AllergyIMPACTHay feverRespiratory Medicine and AllergyDiseaseReview[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract0302 clinical medicineQUALITY-OF-LIFEHDE ALERHealth careMedicine and Health SciencesPERSISTENT ALLERGIC RHINITISMedicineImmunology and Allergy030212 general & internal medicine[SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/AllergologyAIRWAYS ICPComputingMilieux_MISCELLANEOUSRhinitiAIRWAYS ICPs; ARIA; EIP on AHA; ICT; Mobile technology; RhinitisLungmedicin och allergiRhinitisPublic Health Global Health Social Medicine and Epidemiology3. Good healthREAL-LIFEAIRWAYS ICPsARIA; Rhinitis; ICT; EIP on AHA; Mobile technology; AIRWAYS ICPsHay feverCLINICAL-PRACTICE GUIDELINESHEALTHPulmonary and Respiratory Medicinemedicine.medical_specialtyEIP on AHAEUROPEAN INNOVATION PARTNERSHIPImmunologySocio-culturaleClinical decision support systemICT; EIP on AHAPredictive medicine03 medical and health sciencesQuality of life (healthcare)Mobile technologyJournal ArticleMobile technologyAsmaAsthmaScience & TechnologyARIAbusiness.industryAIRWAYS ICPs; ARIA; EIP on AHA; ICT; Mobile technology; Rhinitis;Settore MED/09 - MEDICINA INTERNAAIRWAYS-ICPSCorrectionmedicine.disease2008 UPDATEFebre del fencAsthmaFolkhälsovetenskap global hälsa socialmedicin och epidemiologi030228 respiratory systemFamily medicineICTVISUAL ANALOG SCALEbusiness
researchProduct

Synthesis and photoluminescence properties of hybrid 1D core–shell structured nanocomposites based on ZnO/polydopamine

2020

In the present work, we report on the modelling of processes at the zinc oxide and polydopamine (ZnO/ PDA) interface. The PDA layer was deposited onto ZnO nanorods (NRs) via chemical bath deposition. The defect concentrations in ZnO before and after PDA deposition were calculated and analysed. The ZnONRs/PDA core–shell nanostructures were studied by transmission electron microscopy (TEM), X-ray diffraction (XRD), Raman and Fourier-transform infrared (FTIR) spectroscopy, photoluminescence (PL) measurements, and diffuse reflectance spectroscopy. The TEM and electron energy loss spectroscopy (EELS) measurements confirmed the conformal coating of PDA, while the PL emission from ZnO and ZnONRs/P…

PhotoluminescenceMaterials scienceDiffuse reflectance infrared fourier transformGeneral Chemical EngineeringElectron energy loss spectroscopyGeneral ChemistryX-ray diffraction (XRD)symbols.namesakephotoluminescence (PL)Chemical engineeringTransmission electron microscopysymbolsNanorodzinc oxide and polydopamine (ZnO/ PDA)Fourier transform infrared spectroscopyRaman spectroscopyChemical bath deposition
researchProduct

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B…

2016

Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organizatio…

Pulmons -- Malalties obstructivesVeterinary medicineAllergyPublished ErratumLANGUEDOC-ROUSSILLONAllergyRespiratory Medicine and Allergy[SDV]Life Sciences [q-bio]Aparell respiratori -- MalaltiesOPERATIONAL DEFINITIONAlternative medicineReviewChronic respiratory diseasesGLOBAL ALLIANCESYSTEMS MEDICINE0302 clinical medicineMedicine and Health SciencesImmunology and AllergyMACVIA030212 general & internal medicineAIRWAYS ICPLungmedicin och allergiEIP on AHA; European Innovation Partnership on Active and Healthy Ageing; Chronic respiratory diseases; AIRWAYS ICPs; MACVIA; ARIA; Scaling upGINA STRATEGYAIRWAYSUPDATE ARIA 2008Scaling upRespiratory disease:Outras Ciências Agrárias [Ciências Agrárias]3. Good healthChronic respiratory diseaseALLERGIC RHINITISICPsAIRWAYS ICPsGeneral partnershipAction planErratumLife Sciences & BiomedicineAIRWAYS ICPs; ARIA; Chronic respiratory diseases; EIP on AHA; European Innovation Partnership on Active and Healthy Ageing; MACVIA; Scaling upPulmonary and Respiratory Medicinemedicine.medical_specialtyEIP on AHAAIRWAYS ICPs; ARIA; Chronic respiratory diseases; EIP on AHA; European Innovation Partnership on Active and Healthy Ageing; MACVIA; Scaling up; Immunology and AllergyEmerging technologiesImmunologyREFERENCE SITESocio-culturalePredictive medicine03 medical and health sciencesEuropean Innovation Partnership on Active and Healthy AgeingNursingCritical success factorJournal Articlemedicineddc:610Science & TechnologyARIAbusiness.industrySettore MED/09 - MEDICINA INTERNAAIRWAYS-ICPSmedicine.diseaseIntegrated careAlliance030228 respiratory systemCiências Agrárias::Outras Ciências Agrárias3121 General medicine internal medicine and other clinical medicineFamily medicineImmunologyHealthy ageingbusinessSEVERE ASTHMA
researchProduct

Unicity of biproportion

1994

International audience; The biproportion of S on margins of M is called the intern composition law, K: (S,M) -> X = K(S,M) / X = A S B. A and B are diagonal matrices, algorithmically computed, providing the respect of margins of M. Biproportion is an empirical concept. In this paper, the author shows that any algorithm used to compute a biproportion leads to the me result. Then the concept is unique and no longer empirical. Some special properties are also indicated.

Pure mathematicsupdating matrices[MATH] Mathematics [math]Composition (combinatorics)[SHS.ECO]Humanities and Social Sciences/Economics and Finance15A15 14N05 65Q05biproportionalbiproportionDiagonal matrixCalculus[ SHS.ECO ] Humanities and Social Sciences/Economies and finances[MATH]Mathematics [math][SHS.ECO] Humanities and Social Sciences/Economics and FinanceAnalysisMathematicsRAS
researchProduct